Kaplan-Meier curve survival analysis demonstrated a worse overall survival in patients with lower expression of RBMS3, which is relevant to recurrent glioma (Fig. 3C, Supplementary Fig. 1I). This evidence concerns the gene RBMS3 and central nervous system cancer.